|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Biology, Concordia University, Montreal, Quebec, Canada; Lady Davis Institute, SMBD-Jewish General Hospital, Montreal, Quebec, Canada
2 Smooth Muscle Research Group, University of Calgary, Calgary, Alberta, Canada
3 Biomedical Engineering, Physiology, SUNY, Stony Brook, Stony Brook, NY, USA
4 Lady Davis Institute, SMBD-Jewish General Hospital, Montreal, Quebec, Canada; Centre for Biomedical Research, Biology, University of Victoria, Victoria, BC, Canada
* To whom correspondence should be addressed. E-mail: wcupples{at}uvic.ca.
Non-selective inhibition of nitric oxide synthase augments myogenic autoregulation, an action that implies enhancement of both pressure-induced constriction and pressure-induced dilatation. This pattern is not susceptible to explanation solely by interaction with a vasoconstrictor pathway. To test involvement of the Rho-Rho kinase pathway in modulation of autoregulation by nitric oxide, the selective Rho kinase inhibitor, Y-27632, and the nitric oxide synthase inhibitor L
-nitro-arginine methyl-ester (L-NAME) were infused into the left renal artery of anesthetized rats alone and in combination. They were also infused into isolated, perfused hydronephrotic kidneys to assess myogenic autoregulation over a wide range of perfusion pressure. In vivo, L-NAME alone reduced renal vascular conductance and augmented myogenic autoregulation, shown by increased slope of gain reduction and associated phase peak in the pressure-flow transfer function. Y-27632 (10 µmol/L) strongly dilated the renal vasculature and profoundly inhibited autoregulation in the absence or presence of L-NAME in vivo and in vitro. Afferent arteriolar constriction induced by 30 mmol/L KCl was reversed (-92 ± 3%) by Y-27632. Phenylephrine caused strong renal vasoconstriction, but did not affect autoregulation. In contrast inhibition of neuronal nitric oxide synthase by N5-(1-imino-3-butenyl)-L-ornithine (L-VNIO) did not cause significant vasoconstriction but did augment myogenic autoregulation. Thus vasoconstriction is neither necessary (L-VNIO) nor sufficient (phenylephrine) to explain the augmented myogenic autoregulation induced by L-NAME. The effect of L-VNIO implicates tubuloglomerular feedback and neuronal nitric oxide synthase at the macula densa in regulation of the myogenic mechanism. This conclusion was confirmed by demonstrating that systemic furosemide removed the tubuloglomerular feedback signature from the pressure-flow transfer function and significantly inhibited myogenic autoregulation. Furthermore in the presence of furosemide the augmentation of myogenic autoregulation by L-NAME was significantly reduced. These results provide a potential mechanism to explain interaction between myogenic and TGF-mediated autoregulation.
This article has been cited by other articles:
![]() |
J. Prakash, M. H. de Borst, M. Lacombe, F. Opdam, P. A. Klok, H. van Goor, D. K.F. Meijer, F. Moolenaar, K. Poelstra, and R. J. Kok Inhibition of Renal Rho Kinase Attenuates Ischemia/Reperfusion-Induced Injury J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2086 - 2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Bell, G. F. DiBona, R. Biemiller, and M. W. Brands Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1449 - F1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Iliescu, R. Cazan, G. R. McLemore Jr., M. Venegas-Pont, and M. J. Ryan Renal blood flow and dynamic autoregulation in conscious mice Am J Physiol Renal Physiol, September 1, 2008; 295(3): F734 - F740. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kleinstreuer, T. David, M. J. Plank, and Z. Endre Dynamic myogenic autoregulation in the rat kidney: a whole-organ model Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1453 - F1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Sosnovtseva, A. N. Pavlov, E. Mosekilde, K.-P. Yip, N.-H. Holstein-Rathlou, and D. J. Marsh Synchronization among mechanisms of renal autoregulation is reduced in hypertensive rats Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1545 - F1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Just and W. J. Arendshorst A novel mechanism of renal blood flow autoregulation and the autoregulatory role of A1 adenosine receptors in mice Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1489 - F1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, R. D. Loutzenhiser, and W. A. Cupples Frequency modulation of renal myogenic autoregulation by perfusion pressure Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1199 - R1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oppermann, P. B. Hansen, H. Castrop, and J. Schnermann Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice Am J Physiol Renal Physiol, July 1, 2007; 293(1): F279 - F287. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Cupples and B. Braam Assessment of renal autoregulation Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1105 - F1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, J. Breaks, K. Loutzenhiser, and R. Loutzenhiser Effects of inhibition of the Na+/K+/2Cl- cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole Am J Physiol Renal Physiol, March 1, 2007; 292(3): F999 - F1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Just Mechanisms of renal blood flow autoregulation: dynamics and contributions Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R1 - R17. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shi, C. Lau, and W. A. Cupples Interactive modulation of renal myogenic autoregulation by nitric oxide and endothelin acting through ET-B receptors Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R354 - R361. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |